Refine Results
- view as grid
- view as list
Key Questions About the Current U.S. Monkeypox Outbreak
This brief answers key questions about the U.S. monkeypox outbreak to date and identifies issues that may affect the response going forward.
Issue Brief Read More
Key Global Health Positions and Officials in the U.S. Government
This fact sheet identifies key U.S. government global health positions and officials.
Fact Sheet Read More
43% of Parents with Children Under 5 Newly Eligible for a COVID-19 Vaccine Say They Will “Definitely Not” Get Them Vaccinated
Most Parents Open to Getting Their Young Child Vaccinated Haven’t Yet Spoken to Their Pediatrician Most parents of young children newly eligible for a COVID-19 vaccine are reluctant to get them vaccinated, including 43% who say they will “definitely not” do so, a new KFF COVID-19 Vaccine Monitor survey finds…
News Release Read More
KFF COVID-19 Vaccine Monitor: July 2022
In the wake of the FDA’s emergency use authorization for COVID-19 vaccines for children ages 6 months through 4 years old, many parents remain hesitant to vaccinate their children in this age group, with a slight majority saying they view the vaccine as a bigger risk to their child’s health than getting infected with coronavirus.
Poll Finding Read More
COVID-19 Vaccination Rates Among Children Under 5 Have Peaked and Are Decreasing Just Weeks Into Their Eligibility
Children between the ages of 6 months and 5 years of age finally became eligible for COVID-19 vaccination in the U.S. on June 18, after the Director of the Centers for Disease Control and Prevention (CDC) recommended their use for this population, following emergency use authorization granted by the Food and Drug Administration. Here, we examine the status of vaccine uptake in this group, one month into their eligibility.
Issue Brief Read More
Latest Data on COVID-19 Vaccinations by Race/Ethnicity
KFF is collecting and analyzing data on COVID-19 vaccinations by race/ethnicity to gain increased insight who is receiving the vaccine and whether some groups are facing disparities in vaccination.
Issue Brief Read More
U.S. Global Funding for COVID-19 by Country and Region: An Analysis of USAID Data
As Congress again considers increased assistance for the global response to COVID-19, we look at how current U.S. global COVID-19 emergency funding is being channeled, particularly to countries and regions.
Issue Brief Read More
HIV Testing in the United States
This fact sheet provides information on key HIV testing statistics, testing recommendations as advised by the U.S. Centers for Disease Control and Prevention (CDC), insurance coverage of HIV testing, testing sites and policies, and types of tests available.
Fact Sheet Read More
How Equitable is Access to COVID-19 Treatments?
This issue brief assesses the availability of oral antiviral treatments by county and certain county characteristics, including metro vs. non-metro status, poverty rate, and majority Black, Hispanic, or American Indian or Alaska Native (AIAN).
Issue Brief Read More
The Last Major Phase of the COVID-19 Vaccination Roll-out: Children Under 5
With the FDA authorization of both Moderna and Pfizer’s COVID-19 vaccine for children between the ages of 6 months and 5, the last major phase of the U.S. vaccination roll-out is underway. This brief provides an overview of the characteristics of children under the age of 5 and discusses some issues to consider in rolling out vaccination to this age group.
Issue Brief Read More